Position in SRPT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$39,581,453
-$16,929,109 QoQ
Shares Held
2,202,641
-15.2% QoQ
Ownership
2.09%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 323 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. SRPT ranks #69 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in SRPT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $39,581,453 | 2,202,641 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $56,510,562 | 2,596,993 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $41,159,900 | 1,912,635 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $37,544,874 | 1,948,359 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $25,426,431 | 1,486,926 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $125,860,818 | 1,972,122 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $120,575,325 | 991,655 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $119,033,151 | 953,104 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $414,491,038 | 2,623,361 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $115,016,530 | 888,433 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $133,087,762 | 1,380,149 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $103,696,914 | 855,444 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $111,811,596 | 976,350 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $122,600,604 | 889,506 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $59,224,922 | 457,053 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $43,803,349 | 396,267 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $31,311,238 | 417,706 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $28,944,706 | 370,516 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $21,387,141 | 237,503 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $31,375,593 | 339,269 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $25,241,864 | 324,696 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $14,354,550 | 192,601 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $50,525,731 | 296,356 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $28,579,047 | 203,511 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $33,940,768 | 211,680 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $33,308,783 | 340,511 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||